# Safety and Pharmacokinetics of Phaffia Rhodozyma Astaxanthin

> **NCT03807050** · NA · COMPLETED · sponsor: **NextFerm Technologies LTD** · enrollment: 12 (actual)

## Conditions studied

- Absorption; Chemicals

## Interventions

- **DIETARY_SUPPLEMENT:** Astaxanthin

## Key facts

- **NCT ID:** NCT03807050
- **Lead sponsor:** NextFerm Technologies LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-19
- **Primary completion:** 2018-12-23
- **Final completion:** 2019-02-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03807050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03807050, "Safety and Pharmacokinetics of Phaffia Rhodozyma Astaxanthin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03807050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*